JPRN-C000000103已完成2 期
Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer - Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
Hiroshima Cancer Therapy Development Organization (HiCTDO)0 个研究点目标入组 50 人开始时间: 2005年10月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Symptomatic infectious disease 2)Accompanied serious diseases such as pulmonary fibrosis, interstitial pneumonia, and symptomatic bleeding tendency 3)Peripheral neuropathy>=grade 2 4)Edema>=grade 2 5)Active secondary cancer 6)Symptomatic pleural effusion or ascites 7)Pregnancy or breast feeding 8)Obstructive bowel disease 9)Concomitant therapy with another anticancer drug or flucytocine 10)Past history of allergic reaction to polysorbate 80 11)A past history of drug allergy 12)A past history of allergic reaction to alcohol 13)Symptomatic psychological disease, or uncontrollable diabetes 14)Hemorrhage/bleeding>=grade 3 (NCI-CTC) 15)Decision as ineligible by principal investigator
研究者
相似试验
已完成
1 期
Phase I/II Study of Docetaxel and S-1 Combination Therapy for Advanced Non-small Cell Lung CancerJPRN-C000000281The Tokyo Cooperative Oncology Group60
已完成
2 期
Phase II Study of Docetaxel and TS-1 Combination Therapy for Outpatients with Relapsed or Refractory Non-small Cell Lung cancerRelapsed or Refractory Non-small Cell Lung CancerJPRN-UMIN000000501Outpatient Oncology Unit Kyoto University Hospital40
暂停
2 期
A Phase II trial of S-1 and Docetaxel followed by FEC as neoadjuvant chemotherapy for primary breast cancerBreast CancerJPRN-UMIN000005100Keio University School of Medicine40
已完成
3 期
A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric CancerGastric CancerJPRN-C000000251Japan Clinical Cancer Research Organization628
已完成
不适用
A Phase III Study of Docetaxel plus S-1 versus S-1 Alone in the Treatment of Curatively Resected Stage III Gastric CancerGastric CancerJPRN-UMIN000010337Japan Clinical Cancer Reseach Organization (JACCRO)1,100